Prevention of mortality from hepatitis B and hepatitis C

Lancet

Volumn 368, Issue 9539, 2006, Pages 896-897

  Schiff, Eugene R ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADEFOVIR; ANTIVIRUS AGENT; ENTECAVIR; HEPATITIS B VACCINE; INTERFERON; LAMIVUDINE; NUCLEOSIDE ANALOG; PEGINTERFERON; PLACEBO; RIBAVIRIN; VIRUS DNA;

ARTICLE; BLOOD DONOR; CANCER RISK; CHRONIC HEPATITIS; CONTROLLED STUDY; DISEASE COURSE; DISEASE TRANSMISSION; HEPATITIS B; HEPATITIS C; HUMAN; INTRAVENOUS DRUG ABUSE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; MORTALITY; PRIORITY JOURNAL; REINFECTION; SCREENING TEST; UNSPECIFIED SIDE EFFECT; VIRUS HEPATITIS; VIRUS TRANSMISSION;

EID: 33748306328     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(06)69347-1     Document Type: Note

References (13)

1. Amin J., Law M., Bartlett M., Kaldor J., and Dore G. Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study. Lancet 368 (2006) 938-945
2. Fattovich G., Stroffolini T., Zagni I., and Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 127 suppl 1 (2004) S35-S50
3. Yim H., and Lok A. Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005. Hepatology 43 suppl 1 (2006) S173-S181
4. McMahon B., Bruden D., Petersen K., et al. Antibody levels and protection after hepatitis B vaccination: results of a 15-year follow-up. Ann Intern Med 142 (2005) 333-341
5. Chang M. Impact of hepatitis B vaccination on hepatitis B disease and nucleic acid testing in high-prevalence populations. J Clin Virol 36 suppl 1 (2006) S45-S50
6. Liaw Y., Sung J., Chow W., et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 351 (2004) 1521-1531
7. Keeffe E., Dieterich D., Han S., et al. A treatment algorithm for the management of chronic hepatitis B virus infection in the United States: an update. Clin Gastroenterol Hepatol 4 (2006) 936-962
8. Yim H., Hussain M., Liu Y., Wong S., Fung S., and Lok A. Evolution of multi-drug resistant hepatitis B virus during sequential therapy. Hepatology 44 (2006) 703-712
9. Schreibman I., and Schiff E. Prevention and treatment of recurrent Hepatitis B after liver transplantation: the current role of nucleoside and nucleotide analogues. Ann Clin Microbiol Antimicrob 5 (2006) 8
10. Manns M., Wedemeyer H., and Cornberg M. Treating viral hepatitis C: efficacy, side effects, and complications. Gut 55 (2006) 1350-1359
11. Terrault N., and Berenguer M. Treating hepatitis C infection in liver transplant recipients. Liver Transpl 12 (2006) 1192-1204
12. Edwards K. A new role for pediatric nurses: teaching teen drug users how to sterilize their equipment for prevention of infectious disease; a course outline. Pediatr Nurs 32 (2006) 257-262
13. Williams R. Global challenges in liver disease. Hepatology 44 (2006) 521-526